STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

ALLO

Allogene Therapeutics, Inc.
CIK 0001737287 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
10.5
composite ยท 1 signals ยท CLEAN

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-12 ยท FY 2025-12-31 ยท CLEAN10.5

Restatement predictor

F-Score 0.31 โ€” at or below the population base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2026-03-12) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 0.314,
  "probability": 0.00116,
  "components": {
    "rsst": -0.0863,
    "drec": null,
    "dinv": null,
    "soft": 0.7006,
    "dcs": -1,
    "droa": 0.0105,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1737287/000162828026017242/0001628280-26-017242-index.htm",
    "form": "10-K",
    "filed": "2026-03-12"
  }
}